LCN2 and obesity due to melanocortin 4 receptor deficiency: There are numerous studies available that correlated LCN2 with obesity, insulin resistance and diabetes (Yan et al., 2007; Law et al., 2010) rendering LCN2 as a possible biomarker for assessment of FLD.